163 related articles for article (PubMed ID: 22760170)
21. MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.
Liu W; Au LWC; Abrigo J; Luo Y; Wong A; Lam BYK; Fan X; Kwan PWL; Ma HW; Ng AYT; Chen S; Leung EYL; Ho CL; Wong SHM; Chu WC; Ko H; Lau AYL; Shi L; Mok VCT;
Aging (Albany NY); 2021 May; 13(10):13496-13514. PubMed ID: 34091443
[TBL] [Abstract][Full Text] [Related]
22. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease.
Apostolova LG; Green AE; Babakchanian S; Hwang KS; Chou YY; Toga AW; Thompson PM
Alzheimer Dis Assoc Disord; 2012; 26(1):17-27. PubMed ID: 22343374
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging texture predicts progression to dementia due to Alzheimer disease earlier than hippocampal volume.
Lee S; Lee H; Kim KW;
J Psychiatry Neurosci; 2020 Jan; 45(1):7-14. PubMed ID: 31228173
[TBL] [Abstract][Full Text] [Related]
24. Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease.
Enache D; Cavallin L; Lindberg O; Farahmand B; Kramberger MG; Westman E; Jelic V; Eriksdotter M; Ballard C; Winblad B; Wahlund LO; Aarsland D
J Geriatr Psychiatry Neurol; 2015 Mar; 28(1):40-8. PubMed ID: 25080472
[TBL] [Abstract][Full Text] [Related]
25. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.
Devanand DP; Bansal R; Liu J; Hao X; Pradhaban G; Peterson BS
Neuroimage; 2012 Apr; 60(3):1622-9. PubMed ID: 22289801
[TBL] [Abstract][Full Text] [Related]
26. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
27. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
28. The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.
Tang X; Holland D; Dale AM; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jun; 36(6):2093-117. PubMed ID: 25644981
[TBL] [Abstract][Full Text] [Related]
29. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
[TBL] [Abstract][Full Text] [Related]
30. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.
Jack CR; Petersen RC; Xu Y; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Tangalos EG; Kokmen E
Neurology; 2000 Aug; 55(4):484-89. PubMed ID: 10953178
[TBL] [Abstract][Full Text] [Related]
31. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
Mah L; Binns MA; Steffens DC;
Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
[TBL] [Abstract][Full Text] [Related]
32. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
Chetelat G; Baron JC
Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
[TBL] [Abstract][Full Text] [Related]
33. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
Madusanka N; Choi HK; So JH; Choi BK; Park HG
Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
[TBL] [Abstract][Full Text] [Related]
34. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
35. Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment.
Clerx L; van Rossum IA; Burns L; Knol DL; Scheltens P; Verhey F; Aalten P; Lapuerta P; van de Pol L; van Schijndel R; de Jong R; Barkhof F; Wolz R; Rueckert D; Bocchetta M; Tsolaki M; Nobili F; Wahlund LO; Minthon L; Frölich L; Hampel H; Soininen H; Visser PJ
Neurobiol Aging; 2013 Aug; 34(8):2003-13. PubMed ID: 23540941
[TBL] [Abstract][Full Text] [Related]
36. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
[TBL] [Abstract][Full Text] [Related]
37. How early can we predict Alzheimer's disease using computational anatomy?
Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B;
Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839
[TBL] [Abstract][Full Text] [Related]
38. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
[TBL] [Abstract][Full Text] [Related]
39. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
40. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
Jack CR; Petersen RC; Xu YC; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Waring SC; Tangalos EG; Kokmen E
Neurology; 1999 Apr; 52(7):1397-403. PubMed ID: 10227624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
